Wisconsin Alumni Research Foundation

Drug Discovery & Development
Drug Discovery Development
Diazaphosphacycles, Which Are Used to Catalyze Commercially Important Reactions, and Methods of Synthesis
WARF: P03130US

Inventors: Clark Landis, Wiechang Jin, Jonathan Owen, Thomas Clark, Ryan Nelson

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing chiral phosphines and methods with which to produce them.
Phosphines have many commercial and industrial uses as attachments to rare earth metal catalysts, including specialized uses in asymmetric hydrogenation and other catalytic transformations. Asymmetrical hydrogenation is used to make commercially important products, including biologically active compounds such as pesticides and pharmaceuticals. However, chiral phosphines, which are used in reactions such as asymmetric hydrogenation that yield only one enantiomer of a product, are difficult and expensive to produce, often requiring multistep synthesis.

One specific group of phosphines, 3,4-diazaphospholanes, are five-membered rings containing two nitrogen atoms, two carbon atoms and a phosphorus atom as ring members. Each of the two carbon atom ring members is bonded to one of the ring nitrogen atoms and the ring phosphorus atom. Very few 3,4-diazaphospholanes have been reported and a need exists for chiral phosphines and methods for producing them. A need also remains for transition metal complexes that include chiral phosphines and for transition metal complexes for catalyzing important reactions.
The Invention
UW–Madison researchers have developed diazaphosphacycles and methods for synthesizing them. They further developed transition metal complexes that include diazaphosphacycles and methods for using them in catalytic transformations. The method to synthesize a diazaphosphacycle includes reacting a phosphine with a diimine and optionally one or more equivalents of an acid halide, a sulfonyl halide, a phosphoryl halide or an acid anhydride in the substantial absence of O2 to form the diazaphosphacycle. The phosphine has the formula R1-PH2, where R1 is a substituted or unsubstituted aryl, alkyl, alkenyl, cycloalkyl or ferrocenyl group.
  • Libraries of phosphine catalysts, chiral phosphines and transition metal complexes
Key Benefits
  • Expands the limited availability of chiral phosphines and methods of phosphine synthesis
Additional Information
For More Information About the Inventors
For current licensing status, please contact Mark Staudt at [javascript protected email address] or 608-960-9845